| Original language | English (US) |
|---|---|
| Pages (from-to) | 846-847 |
| Number of pages | 2 |
| Journal | Cancer |
| Volume | 130 |
| Issue number | 6 |
| DOIs | |
| State | Published - Mar 15 2024 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?
Neil D. Gross, Tanguy Y. Seiwert
Research output: Contribution to journal › Editorial › peer-review